SCHEMBL29488462

SCHEMBL29488462

CN(C)CC(C)(C)CNC(=O)/C(=C/CCCCC(=O)NO)COc1cccc2ccccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ HPGD P15428 3/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ OGG1 O15527 1/20 0.39
▸ MAPT P10636 1/20 0.38
▸ TSHR P16473 1/20 0.37
▸ HDAC1 Q13547 5/20 0.36
▸ HDAC6 Q9UBN7 5/20 0.36
▸ HDAC3 O15379 3/20 0.36
▸ HDAC4 P56524 3/20 0.36
▸ HDAC7 Q8WUI4 3/20 0.36
▸ HDAC2 Q92769 3/20 0.36
▸ HDAC10 Q969S8 3/20 0.36
▸ HDAC11 Q96DB2 3/20 0.36
▸ HDAC8 Q9BY41 3/20 0.36
▸ HDAC9 Q9UKV0 3/20 0.36
▸ HDAC5 Q9UQL6 3/20 0.36
▸ HTR1B P28222 2/20 0.35
▸ MEN1 O00255 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1306069 1.00 KDM4E (0.39) KDM4EALDH1A1HPGDTDP1OGG1
SCHEMBL1306064 1.00 KDM4E (0.39) KDM4EALDH1A1HPGDTDP1OGG1
SCHEMBL1306173 0.91 KDM4E (0.45) KDM4EALDH1A1HPGDTDP1OGG1
SCHEMBL1306168 0.91 KDM4E (0.45) KDM4EALDH1A1HPGDTDP1OGG1
SCHEMBL1307236 0.91 CNR2 (0.41) KDM4EALDH1A1HPGDTDP1OGG1
SCHEMBL1307234 0.91 CNR2 (0.41) KDM4EALDH1A1HPGDTDP1OGG1
SCHEMBL1306229 0.85 KDM4E (0.39) KDM4EALDH1A1HPGDTDP1OGG1
SCHEMBL1306233 0.85 KDM4E (0.39) KDM4EALDH1A1HPGDTDP1OGG1
SCHEMBL1306235 0.85 KDM4E (0.39) KDM4EALDH1A1HPGDTDP1OGG1
Cg-200745 SCHEMBL29352975 0.85 HTR1B (0.44) KDM4EALDH1A1HPGDTDP1OGG1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114340672-A Pharmaceutical composition comprising an HDAC inhibitor and an anti-PD 1 antibody or an anti-PD-L1 antibody 晶体基因技术株式会社 2022-04-12 — — CN claimed
CN-112930177-B Pharmaceutical compositions containing alkylcarbamoyl naphthoyl octenoyl hydroxyamide phosphate, tartrate or combinations thereof and methods of making the same 晶体基因技术株式会社 2024-01-30 — — CN disclosed
EP-4155292-A1 METHOD FOR PRODUCING PHARMACEUTICALLY ACCEPTABLE SALT OF ALKYLCARBAMOYL NAPHTHALENYLOXY OCTENOYLHYDROXYAMIDE Crystalgenomics, Inc. (KR) 2023-03-29 — — EP disclosed
CN-114340672-A Pharmaceutical composition comprising an HDAC inhibitor and an anti-PD 1 antibody or an anti-PD-L1 antibody 晶体基因技术株式会社 2022-04-12 — — CN disclosed
CN-110740989-B Pharmaceutically acceptable salts of alkylcarbamoylnaphthoxyoctenoylhydroxyamides or derivatives thereof and process for preparing the same 晶体基因技术株式会社 2022-03-08 — — CN disclosed
Send feedback